Retina Specialists of Tampa is proud to offer our patients the opportunity to access the latest drugs and treatment options. We actively participate in clinical trials focused on developing new therapies for vision threatening conditions. We are committed to the highest quality care with a focus on patient outcomes and safety. Are you interested in participating in clinical research? Ask your Retina Specialist at Retina Specialists of Tampa if you might be a good candidate.
Clinical Trials
Diabetic Macular Edema
Roche/Alluvium BP43445: A Phase II, multicenter, randomized, double masked, active comparator- controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with diabetic macular edema
Uveitis
Synchronicity/YUTIQ®: Phase 4 Study of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation) Study
Wet Age-Related Macular Degeneration
ShoRe: A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)
Retinal Detachment
ONL Therapeutics: A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-Ranging, MultiCenter Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects with Macula-off Rhegmatogenous Retinal Detachment
